Chenli Chang
Impact in
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- IL-33, ST2, and ILC Pathways 3
-
- Asthma and respiratory diseases 4
- Co-authors
- Guohua Zhen (10 shared papers)Yuchen Feng (10 shared papers)Dian Chen (10 shared papers)Jiali Gao (6 shared papers)Gongqi Chen (6 shared papers)Kaiyan Li (1 shared paper)Nan Wang (1 shared paper)Zi Wang (1 shared paper)
In The Last Decade
Chenli Chang
16 papers receiving 284 citations
Peers
Comparison fields: 5 of 56
- Infectious Diseases 60
- Cancer Research 35
- Immunology 47
- Pulmonary and Respiratory Medicine 50
- Physiology 40
Countries citing papers authored by Chenli Chang
This map shows the geographic impact of Chenli Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenli Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenli Chang more than expected).
Fields of papers citing papers by Chenli Chang
This network shows the impact of papers produced by Chenli Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenli Chang. The network helps show where Chenli Chang may publish in the future.
Co-authors
The 25 scholars most cited alongside Chenli Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 80 | |
| 2 | 2023 | 28 | |
| 3 | 2019 | 27 | |
| 4 | 2021 | 22 | |
| 5 | 2022 | 18 | |
| 6 | 2023 | 18 | |
| 7 | 2022 | 15 | |
| 8 | 2023 | 12 | |
| 9 | 2021 | 12 | |
| 10 | 2021 | 12 | |
| 11 | 2021 | 10 | |
| 12 | 2022 | 9 | |
| 13 | 2024 | 8 | |
| 14 | 2024 | 6 | |
| 15 | 2022 | 5 | |
| 16 | 2023 | 5 |
About Chenli Chang
Chenli Chang is a scholar working on Immunology, Physiology, Pulmonary and Respiratory Medicine, Sensory Systems and Immunology and Allergy, having authored 16 papers that have together received 287 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (4 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), IL-33, ST2, and ILC Pathways (3 papers), Delphi Technique in Research (1 paper), COVID-19 Clinical Research Studies (1 paper), Circular RNAs in diseases (1 paper), Allergic Rhinitis and Sensitization (1 paper) and High Altitude and Hypoxia (1 paper). The work is most often cited by research in Infectious Diseases (60 citations), Cancer Research (35 citations), Immunology (47 citations), Pulmonary and Respiratory Medicine (50 citations) and Physiology (40 citations). Chenli Chang has collaborated with scholars based in China and Germany. Frequent co-authors include Guohua Zhen, Yuchen Feng, Dian Chen, Jiali Gao, Gongqi Chen, Kaiyan Li, Nan Wang, Zi Wang, Lingling Yi and Wenliang Wu. Their work appears in journals such as Respiratory Research, Frontiers in Molecular Biosciences, Clinical & Experimental Allergy, International Journal of COPD and Signal Transduction and Targeted Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.